alphaveSHALBY₹145.25

Shalby Limited

Annual Quarterly₹ CrorePeersGKSL GPTHEALTH INDRAMEDCO ARTEMISMED LOTUSEYE DRAGARWQ KMCSHIL KOVAIMcap ₹1,562 Cr

View

In ₹ Crore except Per Share 12 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	238.0	216.0	244.2	278.9	267.5	275.6	264.9	296.4	285.4	272.1	287.4	331.2
Other Income	5.4	4.5	5.0	9.7	7.2	5.4	5.3	7.0	4.5	7.2	8.1	7.4
Total Income	243.4	220.6	249.2	288.6	274.7	281.1	270.2	303.4	289.9	279.4	295.5	338.6
Expenses
+ Cost of Materials Consumed	48.9	7.3	7.8	13.3	66.3	69.4	22.3	15.5	16.7	17.7	14.9	8.2
+ Purchases of Stock-in-Trade	19.5	19.1	17.6	24.3	23.3	28.7	27.6	29.3	31.2	32.1	41.2	42.0
+ Changes in Inventories	-16.2	-11.4	-8.7	-12.9	-23.9	-31.7	-13.5	-6.6	-12.6	-15.5	-12.7	13.4
+ Employee Benefit Expense	38.6	37.8	39.9	44.9	47.1	47.8	44.8	46.5	45.2	47.0	49.6	47.9
+ Finance Costs	3.2	3.6	6.5	8.1	9.3	10.7	10.7	9.4	9.6	10.6	9.3	10.6
+ Depreciation & Amortisation	12.3	12.4	15.6	16.4	16.8	16.3	16.2	16.5	17.4	17.6	18.5	18.7
+ Other Expenses	94.5	120.9	148.7	164.1	122.0	127.6	162.8	170.2	163.3	160.5	165.1	178.1
Total Expenses	200.7	189.8	227.4	258.2	261.0	268.7	271.0	280.8	270.8	270.1	285.9	318.9
EBITDA	52.7	42.3	38.9	45.2	32.6	33.9	20.8	41.5	41.6	30.3	29.4	41.6
EBIT	40.4	29.9	23.3	28.8	15.8	17.6	4.6	25.0	24.2	12.6	10.9	22.8
Profit
PBT before Exceptional Items	42.6	30.8	21.8	30.4	13.7	12.4	-0.7	22.7	19.1	9.2	9.6	19.7
Pretax Income	42.6	30.8	21.8	30.4	13.7	12.4	-0.7	22.7	19.1	9.2	9.6	19.7
+ Current Tax	17.8	14.8	11.8	18.6	13.3	13.1	10.3	18.3	14.3	7.2	4.2	11.9
+ Deferred Tax	-2.7	-3.0	-6.0	-2.9	-2.0	2.2	1.2	-3.4	-2.5	0.8	-13.1	-2.7
Tax Expense	15.1	11.7	5.7	15.7	11.3	15.3	11.4	15.0	11.8	8.0	-8.8	9.2
Net Income	27.6	19.1	16.0	14.7	2.4	-3.0	-12.2	7.7	7.3	1.3	18.5	10.5
+ Net Income — Continuing Ops	27.6	19.1	16.0	14.7	2.4	-3.0	-12.2	7.7	7.3	1.3	18.5	10.5
+ Other Comprehensive Income	-0.4	0.0	0.7	0.0	-0.3	-2.8	0.4	-0.5	-7.0	-2.8	-14.4	0.5
Total Comprehensive Income	27.2	19.1	16.8	14.8	2.1	-5.7	-11.8	7.2	0.2	-1.5	4.0	11.0
Net Income to Common	27.6	19.1	—	—	3.4	0.0	-11.0	8.9	8.4	1.8	18.3	10.8
Minority Interest	-0.0	-0.0	—	—	-1.0	0.0	-1.2	-1.2	-1.1	-0.5	0.1	-0.3
Per Share
Basic EPS	2.57	1.78	1.49	1.37	0.22	-0.28	-1.13	0.71	0.68	0.12	1.72	0.98
Diluted EPS	2.57	1.78	1.49	1.37	0.22	-0.28	-1.13	0.71	0.68	0.12	1.72	0.98
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	0.4	-0.5	-7.0	-2.8	-14.4	0.5
+ Items NOT to be Reclassified to P&L	-0.4	0.1	0.7	0.1	0.1	0.1	-0.4	0.1	-7.1	-0.1	0.4	-0.1
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	-0.2	0.0	-0.1	-0.0	0.0	-0.0
+ Tax on Items NOT to be Reclassified — alt tag	0.0	0.0	0.0	0.0	0.0	0.0	—	—	—	—	—	—
+ Items to be Reclassified to P&L	—	—	—	—	-0.3	-2.8	—	-0.5	—	-2.8	-14.8	0.5
+ Tax on Items to be Reclassified	—	—	—	—	—	—	-0.5	0.0	—	0.0	0.0	0.0
+ Tax on Items to be Reclassified — alt tag	0.0	0.1	0.0	0.0	0.0	0.0	—	—	—	—	—	—
Comprehensive Income — Owners of Parent	-0.4	0.0	16.6	0.0	-0.3	0.0	-10.7	0.5	1.3	-2.8	3.9	11.3
Comprehensive Income — Non-controlling Interests	0.0	0.0	-0.6	0.0	0.0	0.0	-1.1	-0.0	-1.1	0.0	0.2	-0.3
Per Share — as-filed variants
Basic EPS — Continuing Operations	2.57	1.78	1.49	1.37	0.22	-0.28	0.00	0.71	0.68	0.12	1.72	0.98
Diluted EPS — Continuing Operations	2.57	1.78	1.49	1.37	0.22	-0.28	0.00	0.71	0.68	0.12	1.72	0.98
Basic EPS — Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	-1.13	0.00	0.00	0.00	0.00	0.00
Diluted EPS — Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	-1.13	0.00	0.00	0.00	0.00	0.00
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	185.8	201.0	227.5	254.2	201.8	209.3	228.4	258.2	250.2	237.8	244.0	267.5
Gross Margin %	78.07	93.05	93.16	91.14	75.43	75.93	86.24	87.11	87.64	87.38	84.87	80.77
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	42.6	30.8	21.8	30.4	13.7	12.4	-0.7	22.7	19.1	9.2	9.6	19.7
Net Income Adj (tax-effected)	27.6	19.1	16.0	14.7	2.4	-3.0	-12.2	7.7	7.3	1.3	18.5	10.5
EPS Adj	2.57	1.78	1.49	1.37	0.22	-0.28	-1.13	0.71	0.68	0.12	1.72	0.98
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	107.3	107.4	107.4	107.5	107.5	107.5	107.5	107.5	107.5	107.5	107.5	107.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.